Virax Biolabs Group Ltd Equity And Liabilities
Virax Biolabs Group Ltd (VRAX) had Equity And Liabilities of $6.43 million as of 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2025-07-02
- 2025-03-31: Equity And Liabilities $6.43M.
- 2024-03-31: Equity And Liabilities $5.48M.
- 2023-03-31: Equity And Liabilities $9.81M.
- 2022-03-31: Equity And Liabilities $48.71K.
| Period end | Equity And Liabilities |
|---|---|
| 2025-03-31 | $6.43M 20-F · filed 2025-07-02 |
| 2024-03-31 | $5.48M 20-F · filed 2025-07-02 |
| 2023-03-31 | $9.81M 20-F · filed 2024-08-20 |
| 2022-03-31 | $48.71K 20-F · filed 2023-06-14 |
| 2021-03-31 | $39.62K 20-F · filed 2022-08-12 |